Anaplastic large cell lymphoma in a patient with rheumatoid arthritis
Rheumatology International, cilt.31, sa.4, ss.533-535, 2011 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 31 Sayı: 4
- Basım Tarihi: 2011
- Doi Numarası: 10.1007/s00296-009-1184-0
- Dergi Adı: Rheumatology International
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.533-535
- Anahtar Kelimeler: Rheumatoid arthritis, Anaplastic large cell lymphoma, Methotrexate
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
It is known that patients with rheumatoid arthritis (RA) have an increased risk for non-Hodgkin's lymphomas in comparison with the general population. Although increased risk of lymphoma is attributed to the disease activity, the drugs used in the therapy of RA may also cause increased risk of malignancy. Herein, we report on an RA patient who developed non-Hodgkin's lymphoma after methotrexate therapy and review the literature about it. A 74-year-old man with RA had been treated with low-dose methotrexate and subsequently developed anaplastic large cell lymphoma of the T-cell phenotype. Anaplastic large cell lymphoma has been reported rarely in rheumatoid arthritis. © 2009 Springer-Verlag.